Jobs

This is an exciting opportunity to make a significant contribution to the Functional Annotation of Animal Genomes (FAANG; http://www.faang.org) project. You will be responsible for support and development of software to handle data curation, coordination, validation, distribution and visualisation for three FAANG consortia each with a different species and scientific focus (AQUA-FAANG, BovReg and GENE-SWitCH).

JOB REF: SRS 2002


THE COMPANY


Isogenica is a leading innovator in therapeutic antibody development, focused on enabling rapid advancement of next generation antibodies and antibody-based therapeutics through technical innovation.

With an expanding small molecule drug discovery portfolio Artios Pharma is recruiting for a biochemistry and screening scientist. This is an excellent opportunity to join a world class research team in a dynamic, small Biotech company based south of Cambridge, UK. Artios is focused on identifying and developing cancer treatments by exploiting novel targets within the DNA damage response (DDR), a scientific area of high expectation following the success of PARP inhibitors in the clinic. The company is actively working on an exciting portfolio of unique DNA repair projects.

Cambridge Start Up of the Year 2018


Bit Bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At Bit Bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

Cambridge Start Up of the Year 2018


Bit Bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At Bit Bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

Cambridge Start Up of the Year 2018


We are a rapidly growing University of Cambridge spin out aiming to become a defining force in the emerging field of synthetic biology as the leading global supplier of human cells for basic research, drug discovery, and cell therapy. We have established a unique cellular programming technology that allows for unprecedented levels of speed, consistency and purity to generate mature human cells at scale from pluripotent stem cells.

Cambridge Start Up of the Year 2018


Bit Bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At Bit Bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

Cambridge Start Up of the Year 2018


We are a rapidly growing University of Cambridge spin out aiming to become a defining force in the emerging field of synthetic biology as the leading global supplier of human cells for basic research, drug discovery, and cell therapy. We have established a unique cellular programming technology that allows for unprecedented levels of speed, consistency and purity to generate mature human cells at scale from pluripotent stem cells.

Cambridge Start Up of the Year 2018


Bit Bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At Bit Bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

We are looking to recruit a Scientific Database Curator to join the Cellular Structure & 3D Bioimaging team at the European Bioinformatics Institute (EMBL-EBI) located at the Wellcome Genome Campus near Cambridge in the UK.

Pages